Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Asset Utilization Ratio came in at 0.43 in Q2 2026, up 11.26% YoY from 0.39 in Q2 2025, and up 0.92% on a QoQ basis from 0.43 in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 18 years of Asset Utilization Ratio data on file, last reported at 0.43 in Q2 2026.
- Quarterly Asset Utilization Ratio rose 11.26% year-over-year to 0.43 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.43 (up 11.26% YoY) and the FY2025 annual result came in at 0.43, up 7.87% from the prior year.
- Asset Utilization Ratio improved to 0.43 in Q2 2026, from 0.43 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.43 in Q2 2026 to a low of 0.33 in Q1 2022.
- A 5-year average of 0.37 and a median of 0.37 in 2024 frame the typical range for Asset Utilization Ratio.
- The widest YoY moves for Asset Utilization Ratio: up 14.1% in 2025, down 4.32% in 2025.
- Tracing TEVA's Asset Utilization Ratio over 5 years: stood at 0.34 in 2022, then advanced by 9.5% to 0.37 in 2023, then climbed by 1.33% to 0.38 in 2024, then climbed by 14.1% to 0.43 in 2025, then grew by 1.22% to 0.43 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.43 (Q2 2026), 0.43 (Q1 2026), and 0.43 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 0.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.43 |
| Mar 31, 2026 | 0.43 |
| Dec 31, 2025 | 0.43 |
| Sep 30, 2025 | 0.39 |
| Jun 30, 2025 | 0.39 |
| Mar 31, 2025 | 0.39 |
| Dec 31, 2024 | 0.38 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | 0.39 |
| Mar 31, 2024 | 0.37 |
| Dec 31, 2023 | 0.37 |
| Sep 30, 2023 | 0.36 |
| Jun 30, 2023 | 0.35 |
| Mar 31, 2023 | 0.34 |
| Dec 31, 2022 | 0.34 |
| Sep 30, 2022 | 0.34 |
| Jun 30, 2022 | 0.33 |
| Mar 31, 2022 | 0.33 |
| Dec 31, 2021 | 0.33 |
| Sep 30, 2021 | 0.33 |